Type 2 Diabetes Treatment in 2026: How to Pick the Right Drug
How to choose among metformin, SGLT2 inhibitors, GLP-1 receptor agonists and the rest by comorbidity rather than by A1c alone — the cardiorenal-first framework the current ADA and AACE standards are built on.